Literature DB >> 23507312

A case-cohort study examining lifetime exposure to inorganic arsenic in drinking water and diabetes mellitus.

Katherine A James1, Julie A Marshall, John E Hokanson, Jaymie R Meliker, Gary O Zerbe, Tim E Byers.   

Abstract

BACKGROUND: Consumption of drinking water with high levels of inorganic arsenic (over 500 μg/L) has been associated with type II diabetes mellitus (DM), but previous studies have been inconclusive about risks at lower levels (<100 μg/L). We present a case-cohort study based on individual estimates of lifetime arsenic exposure to examine the relationship between chronic low-level arsenic exposure and risk of DM.
METHODS: This case-cohort study included 141 cases of DM diagnosed between 1984 and 1998 as part of the prospective San Luis Valley Diabetes Study. A comparison sub-cohort of 488 participants was randomly sampled from 936 eligible participants who were disease free at baseline. Individual lifetime arsenic exposure estimates were determined using a methodology that incorporates the use of a structured interview to determine lifetime residence and employment history, geospatial modeling of arsenic concentrations in drinking water, and urine arsenic concentrations. A Cox proportional hazards model with known DM risk factors as time-dependent covariates was used to assess the association between lifetime exposure to inorganic arsenic in drinking water and incident DM.
RESULTS: Our findings show a significant association between inorganic arsenic exposure and DM risk (hazard ratio [HR]=1.27, 95%=1.01, 1.59 per 15 μg/L) while adjusting for ethnicity and time varying covariates age, body mass index and physical activity level.
CONCLUSIONS: Exposure to low-level inorganic arsenic in drinking water is associated with increased risk for type II DM in this population based on a comprehensive lifetime exposure assessment.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23507312     DOI: 10.1016/j.envres.2013.02.005

Source DB:  PubMed          Journal:  Environ Res        ISSN: 0013-9351            Impact factor:   6.498


  33 in total

Review 1.  Environmental chemicals and type 2 diabetes: an updated systematic review of the epidemiologic evidence.

Authors:  Chin-Chi Kuo; Katherine Moon; Kristina A Thayer; Ana Navas-Acien
Journal:  Curr Diab Rep       Date:  2013-12       Impact factor: 4.810

2.  Risk of death from cardiovascular disease associated with low-level arsenic exposure among long-term smokers in a US population-based study.

Authors:  Shohreh F Farzan; Yu Chen; Judy R Rees; M Scot Zens; Margaret R Karagas
Journal:  Toxicol Appl Pharmacol       Date:  2015-06-03       Impact factor: 4.219

3.  Identification of novel gene targets and putative regulators of arsenic-associated DNA methylation in human urothelial cells and bladder cancer.

Authors:  Julia E Rager; Sloane K Tilley; Samantha E Tulenko; Lisa Smeester; Paul D Ray; Andrew Yosim; Jenna M Currier; María C Ishida; Maria Del Carmen González-Horta; Blanca Sánchez-Ramírez; Lourdes Ballinas-Casarrubias; Daniela S Gutiérrez-Torres; Zuzana Drobná; Luz M Del Razo; Gonzalo G García-Vargas; William Y Kim; Yi-Hui Zhou; Fred A Wright; Miroslav Stýblo; Rebecca C Fry
Journal:  Chem Res Toxicol       Date:  2015-06-03       Impact factor: 3.739

4.  Low to moderate toenail arsenic levels in young adulthood and incidence of diabetes later in life: findings from the CARDIA Trace Element study.

Authors:  Kefeng Yang; Pengcheng Xun; Mercedes Carnethon; April P Carson; Liping Lu; Jie Zhu; Ka He
Journal:  Environ Res       Date:  2019-01-25       Impact factor: 6.498

5.  Predicting arsenic concentrations in groundwater of San Luis Valley, Colorado: implications for individual-level lifetime exposure assessment.

Authors:  Katherine A James; Jaymie R Meliker; Barbara E Buttenfield; Tim Byers; Gary O Zerbe; John E Hokanson; Julie A Marshall
Journal:  Environ Geochem Health       Date:  2014-01-16       Impact factor: 4.609

6.  Targeted metabolomics to understand the association between arsenic metabolism and diabetes-related outcomes: Preliminary evidence from the Strong Heart Family Study.

Authors:  Miranda J Spratlen; Maria Grau-Perez; Jason G Umans; Joseph Yracheta; Lyle G Best; Kevin Francesconi; Walter Goessler; Teodoro Bottiglieri; Mary V Gamble; Shelley A Cole; Jinying Zhao; Ana Navas-Acien
Journal:  Environ Res       Date:  2018-09-27       Impact factor: 6.498

7.  Estimation of Inorganic Arsenic Exposure in Populations With Frequent Seafood Intake: Evidence From MESA and NHANES.

Authors:  Miranda R Jones; Maria Tellez-Plaza; Dhananjay Vaidya; Maria Grau; Kevin A Francesconi; Walter Goessler; Eliseo Guallar; Wendy S Post; Joel D Kaufman; Ana Navas-Acien
Journal:  Am J Epidemiol       Date:  2016-10-04       Impact factor: 4.897

8.  Biochemical investigation of association of arsenic exposure with risk factors of diabetes mellitus in Pakistani population and its validation in animal model.

Authors:  Kanwal Rehman; Fiza Fatima; Muhammad Sajid Hamid Akash
Journal:  Environ Monit Assess       Date:  2019-07-25       Impact factor: 2.513

9.  Arsenic exposure, diabetes-related genes and diabetes prevalence in a general population from Spain.

Authors:  Maria Grau-Perez; Ana Navas-Acien; Inmaculada Galan-Chilet; Laisa S Briongos-Figuero; David Morchon-Simon; Jose D Bermudez; Ciprian M Crainiceanu; Griselda de Marco; Pilar Rentero-Garrido; Tamara Garcia-Barrera; Jose L Gomez-Ariza; Jose A Casasnovas; Juan C Martin-Escudero; Josep Redon; F Javier Chaves; Maria Tellez-Plaza
Journal:  Environ Pollut       Date:  2018-02-21       Impact factor: 8.071

10.  The Association of Arsenic Exposure and Arsenic Metabolism With the Metabolic Syndrome and Its Individual Components: Prospective Evidence From the Strong Heart Family Study.

Authors:  Miranda J Spratlen; Maria Grau-Perez; Lyle G Best; Joseph Yracheta; Mariana Lazo; Dhananjay Vaidya; Poojitha Balakrishnan; Mary V Gamble; Kevin A Francesconi; Walter Goessler; Shelley A Cole; Jason G Umans; Barbara V Howard; Ana Navas-Acien
Journal:  Am J Epidemiol       Date:  2018-08-01       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.